Document is current
Any future updates will be listed below
-
Authors
Mutebi, Francis
von Samson-Himmelstjerna, Georg
Feldmeier, Hermann
Mencke, Norbert
Waiswa, Charles
Krücken, Jürgen
-
Funding
Funding for this research was provided by:
German Academic Exchange Service
Bayer HealthCare
German Research Foundation (405027164, 405027164)
Freie Universität Berlin
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 5 February 2025
First Online: 21 February 2025
Declarations
:
: Ethical committees of the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Uganda (ref. VAB/REC/14/101) and the National Council of Science and Technology (ref. HS 1621) approved the study. Participation was voluntary and written consent was obtained from pig owners. Pigs recruited in the study were treated against tungiasis using Supona®, an aerosol with proven efficacy against tungiasis [] on termination of the study until all lesions were cleared. In addition, participating households were handled anonymously and utmost confidence was strictly adhered to since T. penetrans infections amongst humans in households are associated with stigma.
: All participating households gave written consent for publication of the study findings from anonymised data.
: The authors declare no competing interests.
